Paroxetine for Anxiety in Patients with Chronic Obstructive Pulmonary Disease(emphysema).
Phase 4
- Conditions
- AnxietyCOPDMental Health - AnxietyRespiratory - Chronic obstructive pulmonary disease
- Registration Number
- ACTRN12613000458730
- Lead Sponsor
- Department of Respiratory Medicine, TQEH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Patients with:
COPD, as confirmed by lung function testing ie FEV1/FVC <0.70, and
Anxiety symptoms with Beck Anxiety Inventory (BAI) score of >15.
Exclusion Criteria
Severe cognitive impairment.
Terminal cancer.
Pregnancy and lactation.
Unstable psychiatric condition like schizephrenia or active suicidal ideation.
Current use of MAOinhibitors.
Intolerance or allergy to SSRIs.
Prolonged QT interval on ECG.
Current acute exacerbation of COPD
Current use of regular antianxiety and antidepressant medications.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Anxiety as measured by Beck Anxiety Inventory (mean difference) [4 months and 12 months.]
- Secondary Outcome Measures
Name Time Method